summary_id,indication,modality,n_dosed,n_with_durable_response,response_rate_pct,median_follow_up_days,ae_rate_per_pt_year,sae_rate_per_pt_year,crs_rate_pct,icans_rate_pct,mortality_rate_pct,dropout_rate_pct,cohort_phase
T00001,Large B-Cell Lymphoma,CAR_T,15,11,73.33,550,21.369,0.708,86.67,26.67,0.0,7.97,Cohort_C
T00002,Hemophilia A,AAV,7,5,71.43,665,8.076,0.314,28.57,0.0,0.0,2.07,Cohort_A
T00003,Multiple Myeloma,CAR_T,19,10,52.63,713,15.25,0.727,89.47,26.32,0.0,7.39,Cohort_B
T00004,B-ALL,CAR_T,17,8,47.06,591,18.346,0.945,58.82,41.18,5.88,4.76,Cohort_C
T00005,Metachromatic Leukodystrophy,LENTIVIRAL,14,8,57.14,563,11.438,0.37,0.0,0.0,50.0,2.21,Cohort_B
T00006,Large B-Cell Lymphoma,CAR_T,31,19,61.29,720,14.914,0.605,90.32,25.81,3.23,2.89,Cohort_B
T00007,Large B-Cell Lymphoma,CAR_T,31,18,58.06,627,16.92,0.601,74.19,29.03,3.23,6.93,Cohort_A
T00008,Duchenne Muscular Dystrophy,AAV,14,9,64.29,568,8.078,0.23,0.0,0.0,14.29,11.83,Cohort_A
T00009,Hemophilia A,AAV,13,10,76.92,666,6.703,0.379,15.38,0.0,0.0,9.22,Cohort_B
T00010,Beta-Thalassemia (TDT),CRISPR,7,4,57.14,694,11.345,0.075,0.0,0.0,28.57,6.19,Cohort_A
T00011,Multiple Myeloma,CAR_T,13,12,92.31,669,15.99,0.504,84.62,30.77,0.0,3.64,Cohort_A
T00012,B-ALL,CAR_T,29,17,58.62,658,16.412,0.727,82.76,31.03,3.45,6.35,Cohort_B
T00013,Sickle Cell Disease,CRISPR,33,22,66.67,584,12.973,0.303,0.0,0.0,45.45,4.86,Cohort_B
T00014,SMA Type 1,AAV,21,16,76.19,686,5.979,0.431,4.76,0.0,9.52,7.45,Cohort_B
T00015,B-ALL,CAR_T,16,8,50.0,629,15.087,0.725,75.0,37.5,0.0,2.77,Cohort_A
T00016,Beta-Thalassemia (TDT),CRISPR,7,7,100.0,658,10.619,0.079,0.0,0.0,71.43,6.44,Cohort_C
T00017,Metachromatic Leukodystrophy,LENTIVIRAL,2,1,50.0,547,10.343,0.0,0.0,0.0,50.0,6.73,Cohort_C
T00018,Duchenne Muscular Dystrophy,AAV,12,6,50.0,678,7.178,0.359,0.0,0.0,8.33,9.18,Cohort_C
T00019,Duchenne Muscular Dystrophy,AAV,22,12,54.55,724,5.523,0.229,0.0,0.0,27.27,7.67,Cohort_B
T00020,Sickle Cell Disease,CRISPR,14,9,64.29,653,11.499,0.24,0.0,0.0,50.0,8.23,Cohort_C
T00021,Beta-Thalassemia (TDT),CRISPR,14,7,50.0,712,9.923,0.146,0.0,0.0,35.71,8.96,Cohort_B
T00022,Hemophilia A,AAV,9,6,66.67,673,6.026,0.241,33.33,0.0,11.11,9.23,Cohort_C
T00023,Sickle Cell Disease,CRISPR,20,8,40.0,613,11.938,0.119,0.0,0.0,50.0,2.02,Cohort_A
T00024,Leber Congenital Amaurosis,AAV,7,7,100.0,588,6.74,0.443,0.0,0.0,0.0,5.66,Cohort_C
T00025,Leber Congenital Amaurosis,AAV,5,3,60.0,615,7.241,0.119,0.0,0.0,0.0,8.02,Cohort_B
T00026,Multiple Myeloma,CAR_T,15,7,46.67,573,18.091,0.552,46.67,53.33,13.33,3.17,Cohort_C
T00027,SMA Type 1,AAV,10,8,80.0,633,5.882,0.288,0.0,0.0,0.0,2.92,Cohort_C
T00028,SMA Type 1,AAV,16,13,81.25,659,6.681,0.277,6.25,0.0,12.5,7.47,Cohort_A
T00029,Metachromatic Leukodystrophy,LENTIVIRAL,11,5,45.45,591,12.127,0.449,0.0,0.0,54.55,7.3,Cohort_A
T00030,ATTR Amyloidosis,LNP_mRNA,18,9,50.0,560,6.952,0.181,0.0,0.0,5.56,11.54,Cohort_B
T00031,ATTR Amyloidosis,LNP_mRNA,7,4,57.14,577,6.055,0.09,0.0,0.0,14.29,4.47,Cohort_A
T00032,Hemophilia B,AAV,5,5,100.0,703,6.75,0.623,0.0,0.0,0.0,8.1,Cohort_A
T00033,ATTR Amyloidosis,LNP_mRNA,8,7,87.5,686,5.52,0.266,0.0,0.0,12.5,3.73,Cohort_C
T00034,Hemophilia B,AAV,6,3,50.0,626,7.483,0.389,0.0,0.0,0.0,9.82,Cohort_C
T00035,Hemophilia B,AAV,8,4,50.0,674,5.483,0.406,12.5,0.0,0.0,7.54,Cohort_B
T00036,Leber Congenital Amaurosis,AAV,1,0,0.0,605,11.463,0.0,0.0,0.0,0.0,7.04,Cohort_A